Success Metrics

Active Trials
2(33%)

Phase Distribution

Ph phase_3
3
50%
Ph phase_2
1
17%
Ph phase_1
1
17%

Phase Distribution

1

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Terminated(2)
Other(1)

Detailed Status

Active, not recruiting2
Withdrawn2
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 33 (60.0%)

Trials by Status

active_not_recruiting233%
unknown117%
withdrawn233%
not_yet_recruiting117%

Recent Activity

2 active trials
Showing 5 of 6
not_yet_recruitingphase_3

A Study to Investigate the Safety, Pharmacokinetics (PK), and Efficacy of Garetosmab in Children and Adolescents With Fibrodysplasia Ossificans Progressiva (FOP)

NCT07559513
active_not_recruitingphase_3

A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)

NCT05394116
unknown

An Expanded Access Program of Garetosmab in Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)

NCT07301450
active_not_recruitingphase_2

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

NCT06299098
withdrawnphase_1

Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal Women

NCT06970405
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07559513Phase 3

A Study to Investigate the Safety, Pharmacokinetics (PK), and Efficacy of Garetosmab in Children and Adolescents With Fibrodysplasia Ossificans Progressiva (FOP)

Not Yet Recruiting
NCT05394116Phase 3

A Study to Assess Safety, Tolerability and Efficacy of Garetosmab Versus Placebo Administered Intravenously (IV) in Adult Participants With Fibrodysplasia Ossificans Progressiva (FOP)

Active Not Recruiting
NCT07301450

An Expanded Access Program of Garetosmab in Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)

Unknown
NCT06299098Phase 2

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

Active Not Recruiting
NCT06970405Phase 1

Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal Women

Withdrawn
NCT04577820Phase 3

Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)

Withdrawn

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6